 We think that Alnylam Pharmaceuticals stock, a pharmaceutical company focused on RNA interference therapeutics for genetically defined diseases, currently is a better pick compared to Haemonetics NYSE: HAE, best known for its blood and plasma supplies and services, despite ALNY being the more. 